Merck Animal Health Announces Availability of Novel Canine Oncology Therapy to Veterinary Specialists Practicing Oncology Nationwide
Gilvetmab Is Available to Veterinary Specialists Practicing Oncology to Treat Dogs with Mast Cell Tumors and Melanoma Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced that its caninized monoclonal antibody gilvetmab (gil-VET-mab) is now available […]